#cardiovascular health

4 articles

**Approach:** Conceptual metaphor. **Palette:** Bold color field (teal).

A single flexible garden hose, shot from a low three-quarter angle, lies coiled against a saturated teal seamless backdrop. One half of the hose is pale and wrinkled, with a stiff, cracked rubber texture and a visible kink. The other half is supple, glossy and smoothly curved. A thin stream of water arcs from the open end, catching the light. Soft, large-source studio light comes from the upper left and casts gentle, neutral grey shadows with no blue cast. A small electric green brass fitting, with a clean metallic sheen, sits where the two halves meet. The shallow depth of field blurs the coils in the foreground. The mood is quietly doubtful but curious, as if the result is promising and still unproven. There is no text anywhere in the frame.

Magnesium Eased Stiff Arteries After 6 Months—Then Came a Null Trial

BY DR. SYNAPSE · Oct 29, 2026

For 12 weeks, magnesium did nothing measurable to arterial stiffness. At week 24, a 52-person randomized trial found pulse wave velocity improved by 1.0 m/s versus placebo, with no change in blood pressure. It's an eye-catching result for anyone interested in vascular aging. But a larger 2022 follow-up from the same group, testing 164 adults and three magnesium forms, found no significant effect. Here's what the original study showed, where it falls short, and what to make of the conflicting evidence.

Approach 3, the human outcome, in palette D, a bold color field.

Close-up of an older adult's bare upper arm, seen from a slightly high three-quarter angle, with a blood pressure cuff wrapped snugly above the elbow. The cuff is matte graphite grey with a coiled rubber tube trailing out of frame. The arm shows real skin texture, freckles and fine creases, and the face is out of frame. The backdrop is a saturated, flat tomato-red wall. A small electric green LED glows on the cuff's digital monitor at the edge of the frame, with its display blurred and unreadable. Soft, even studio light comes from the left, with gentle shadows and no blue cast. Shallow depth of field keeps the cuff edge and skin pores sharp. The mood is calm, clinical and quietly hopeful.

supplements

NMN and Blood Pressure: 10 Trials Pooled, Over-60s Dropped Most

BY NOVA CHEN · Oct 26, 2026

A new meta-analysis in Nutrients pooled 10 randomized trials of NMN, the popular NAD+ precursor, to see whether it affects blood pressure. Across 349 participants, NMN modestly lowered diastolic pressure by about 2.15 mmHg, while the overall systolic change was not significant. In adults 60 and older, systolic pressure dropped by roughly 3.94 mmHg. But the sample is small, the analysis used a common-effects model, and the authors call the evidence preliminary. Here is what the numbers mean, what they don't, and why NMN is no substitute for blood pressure medication.

Approach: conceptual metaphor. Palette: bold color field (D).

Subject: a clear glass tube-shaped pipe, cut in cross-section, sitting on a saturated mustard-yellow backdrop. Its inner wall is lined with chalky, white mineral crust that narrows the opening on one end and thins out toward the other, showing progression slowing. A single thin electric green thread runs through the clear center as a small accent.

Camera: low three-quarter angle, shallow depth of field, macro lens, with the narrowed end sharp in the foreground and the clear end softly blurred behind.

Lighting: bright, soft studio light from the upper left with crisp highlights on the glass and a clean, warm-grey shadow cast on the yellow surface. No blue cast.

Mood: calm, precise, cautiously optimistic. The mineral texture should look real, gritty and crystalline, not cartoonish. No text or labels.

supplements

720 mcg Vitamin K2 + D3 Slowed Artery Calcification ~21% in RCT

BY DR. SYNAPSE · Oct 26, 2026

A two-year, double-blind trial of 400 people with severe coronary calcification found that high-dose vitamin K2 plus D3 slowed the rise in artery calcium by roughly 21% versus placebo (196 vs 248 AU). Plaque imaging showed no increase in noncalcified plaque, a reassuring sign. But the supplement slowed progression and did not reverse calcium, and the study did not measure heart attacks or deaths. The participants were older (median age 71) with advanced disease, so the results may not apply to everyone. Here is what the DANCODE trial showed, what it did not, and why anyone on warfarin should talk to a doctor first.

Macro photograph at a low 30-degree angle of two tiny mounds on a glossy, saturated teal acrylic surface. The left mound is orange-yellow CoQ10 crystalline powder with visible faceted flakes. The right mound is dull metallic grey selenium granules. A hairline crack runs across the acrylic between them, hinting at the catch. Hard, clean studio light from the upper left throws crisp, short shadows and sparkles on the crystal edges. The background falls softly out of focus, with a thin electric green reflection streaking across the glossy surface. The palette is bold color field: teal against orange, with silver-grey accents. The mood is precise, curious and cautionary, like a lab specimen photographed for a magazine. Photorealistic, shallow depth of field, no text.

longevity

Two Cheap Supplements Cut Heart Deaths by Half. There's a Catch.

BY NOVA CHEN · Oct 20, 2026

Two inexpensive supplements, CoQ10 and selenium, were linked to a drop in cardiovascular deaths from 12.6% to 5.9% in elderly Swedes. Heart-strain biomarkers and echocardiograms improved as well. But the trial enrolled just 443 people in a selenium-poor country, and it can't say which nutrient did the work. Here's what the KiSel-10 study actually showed, who it may apply to, and the safety limits to know before you try it.